Sign in
Shelby

Shelby

Managing Director and Senior Equity Analyst at RBC Capital Markets

Oakville, ON, CA

Shelby Tucker is a Managing Director and Senior Equity Analyst at RBC Capital Markets, specializing in utility sector research with a particular focus on covering major companies such as Southern Company. Known for providing in-depth investment analysis in utilities, Tucker has earned industry recognition for accurate and actionable stock recommendations, though specific performance metrics such as TipRanks rankings or published success rates are not publicly available. Tucker's career trajectory includes a longstanding tenure at RBC Capital Markets, where they have established themselves as a key voice in utility equity research, though detailed information about prior firms and start dates remains undisclosed. Professionally, Shelby Tucker holds securities industry credentials and is registered with FINRA, maintaining all necessary analyst licenses.

Shelby's questions to Ultragenyx Pharmaceutical (RARE) leadership

Question · Q3 2025

Shelby asked about the loss of exclusivity for Setrusumab, specifically regarding foundational IP expiring in 2028 and whether additional IP estate could extend protection beyond that timeframe.

Answer

Emil Kakkis, CEO and President, highlighted that orphan drug designation provides protection well past 2030. He also mentioned that biologics rarely face typical loss of exclusivity challenges and that additional IP related to discoveries in chronic treatment are being developed, positioning the program well for future protection.

Ask follow-up questions

Fintool

Fintool can predict Ultragenyx Pharmaceutical logo RARE's earnings beat/miss a week before the call

Let Fintool AI Agent track Shelby for you

Get briefed when they ask questions on calls

Best AI Agent for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Try Fintool for free